Patents by Inventor Elena Carceller González

Elena Carceller González has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS
    Publication number: 20230026909
    Abstract: The invention relates to compounds of Formula (I) as described herein, useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy.
    Type: Application
    Filed: February 10, 2022
    Publication date: January 26, 2023
    Inventors: Elena CARCELLER GONZÁLEZ, Alberto ORTEGA MUÑOZ, Jorge SALAS SOLANA
  • METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR
    Publication number: 20220389478
    Abstract: The invention relates to methods to determine KDM1A target engagement and chemoprobes useful therefor. In particular, the invention relates to non-peptidic KDM1A chemoprobes carrying a tag or label that can be used to assess KDM1A target engagement in cells and tissues. These chemoprobes can also be used to identify KDM1A interacting factors and analyze expression levels of KDM1A.
    Type: Application
    Filed: December 16, 2021
    Publication date: December 8, 2022
    Inventors: Elena CARCELLER GONZÁLEZ, Tamara MAES, Cristina MASCARO CRUSAT, Alberto ORTEGA MUÑOZ
  • 3-(2-(HETEROARYL)-PYRIDIN-4-YL)-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOLE DERIVATIVES AS HDAC6 INHIBITORS
    Publication number: 20220298156
    Abstract: The invention relates to compounds as described herein, useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 22, 2022
    Inventors: Elena CARCELLER GONZÁLEZ, Alberto ORTEGA MUÑOZ, Jorge SALAS SOLANA
  • Methods to determine KDM1A target engagement and chemoprobes useful therefor
    Patent number: 11034991
    Abstract: The invention relates to methods to determine KDM1A target engagement and chemoprobes useful therefor. In particular, the invention relates to non-peptidic KDM1A chemoprobes carrying a tag or label that can be used to assess KDM1A target engagement in cells and tissues. These chemoprobes can also be used to identify KDM1A interacting factors and analyze expression levels of KDM1A.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: June 15, 2021
    Assignee: Oryzon Genomics S.A.
    Inventors: Elena Carceller González, Tamara Maes, Cristina Mascaro Crusat, Alberto Ortega Muñoz
  • 1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS
    Publication number: 20200339569
    Abstract: The invention relates to compounds of Formula (I) as described herein, useful as histone deacetylase 6 (HDAC6) inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy.
    Type: Application
    Filed: December 5, 2018
    Publication date: October 29, 2020
    Inventors: Elena CARCELLER GONZÁLEZ, Alberto ORTEGA MUÑOZ, Jorge SALAS SOLANA
  • DIPEPTIDYL KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF FAT ACCUMULATION
    Publication number: 20190270770
    Abstract: The present invention relates to the use of dipeptidyl ketoamide compounds for preventing accumulation of triglycerides in adipose tissue or for reducing the amount of triglycerides in adipose tissue in a subject in need thereof and to novel dipeptidyl ketoamide compounds.
    Type: Application
    Filed: May 16, 2019
    Publication date: September 5, 2019
    Inventors: Jesús LLENAS CALVO, Miriam ROYO EXPOSITO, Elena CARCELLER GONZÁLEZ, Unai ELEZCANO DONAIRE, Sergio RODRIGUEZ ESCRICH, Enrique VAZQUEZ TATAY
  • Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
    Patent number: 10294269
    Abstract: The present invention relates to the use of dipeptidyl ketoamide compounds for preventing accumulation of triglycerides in adipose tissue or for reducing the amount of triglycerides in adipose tissue in a subject in need thereof and to novel dipeptidyl ketoamide compounds.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: May 21, 2019
    Assignee: LANDSTEINER GENMED, S.L.
    Inventors: Jesús Llenas Calvo, Miriam Royo Exposito, Elena Carceller González, Unai Elezcano Donaire, Sergio Rodriguez Escrich, Enrique Vazquez Tatay
  • METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL THEREFOR
    Publication number: 20190085372
    Abstract: The invention relates to methods to determine KDM1A target engagement and chemoprobes useful therefor. In particular, the invention relates to non-peptidic KDM1A chemoprobes carrying a tag or label that can be used to assess KDM1A target engagement in cells and tissues. These chemoprobes can also be used to identify KDM1A interacting factors and analyze expression levels of KDM1A.
    Type: Application
    Filed: March 16, 2017
    Publication date: March 21, 2019
    Inventors: Elena CARCELLER GONZÁLEZ, Tamara MAES, Cristina MASCARO CRUSAT, Alberto ORTEGA MUN0Z
  • DIPEPTIDYL KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF FAT ACCUMULATION
    Publication number: 20180237473
    Abstract: The present invention relates to the use of dipeptidyl ketoamide compounds for preventing accumulation of triglycerides in adipose tissue or for reducing the amount of triglycerides in adipose tissue in a subject in need thereof and to novel dipeptidyl ketoamide compounds.
    Type: Application
    Filed: September 8, 2015
    Publication date: August 23, 2018
    Inventors: Jesús LLENAS CALVO, Miriam ROYO EXPOSITO, Elena CARCELLER GONZÁLEZ, Unai ELEZCANO DONAIRE, Sergio RODRIGUEZ ESCRICH, Enrique VAZQUEZ TATAY
  • Substituted benzamides with activity towards EP4 receptors
    Patent number: 9926276
    Abstract: The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP4 receptor as well as to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: March 27, 2018
    Assignee: DRACONIS PHARMA, S.L.
    Inventors: Marina Virgili Bernado, Elena Carceller Gonzalez, Jordi Salas Solana
  • EP1 receptor ligands
    Patent number: 9518015
    Abstract: The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: December 13, 2016
    Assignee: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Antoni Torrens Jover, Ramon Mercè Vidal, Francesc Xavier Caldentey Frontera, Antonio David Rodríguez Garrido, Elena Carceller González, Jordi Salas Solana
  • SUBSTITUTED BENZAMIDES WITH ACTIVITY TOWARDS EP4 RECEPTORS
    Publication number: 20150376129
    Abstract: The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP4 receptor as well as to pharmaceutical compositions comprising them.
    Type: Application
    Filed: February 7, 2014
    Publication date: December 31, 2015
    Applicant: DRACONIS PHARMA, S.L.
    Inventors: Marina VIRGILI BERNADO, Elena CARCELLER GONZALEZ, Jordi SALAS SOLANA
  • Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
    Patent number: 8901146
    Abstract: Aminoalkylpyrimidine derivatives of formula I, wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine H4 receptor antagonists.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: December 2, 2014
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Elena Carceller Gonzalez, Marina Virgili Bernado, Robert Soliva Soliva, Carles Ferrer Costa
  • EP1 RECEPTOR LIGANDS
    Publication number: 20140323475
    Abstract: The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
    Type: Application
    Filed: September 14, 2012
    Publication date: October 30, 2014
    Inventors: Antoni Torrens Jover, Ramon Mercé Vidal, Francesc Xavier Caldentey Frontera, Antonio David Rodríguez Garrido, Elena Carceller González, Jordi Salas Solana
  • 4-aminopyrimidine derivatives as histamine Hreceptor antagonists
    Patent number: 8431580
    Abstract: 4-Aminopyrimidine derivatives of formula (I) that are useful as histamine H4 receptor antagonists.
    Type: Grant
    Filed: December 18, 2008
    Date of Patent: April 30, 2013
    Assignee: Palau Pharma, S.A.
    Inventors: Elena Carceller González, Eva Maria Medina Fuentes, Robert Soliva Soliva, Marina Virgili Bernadó, Josep Martí Via
  • AMINOALKYLPYRIMIDINE DERIVATIVES AS HISTAMINE H4 RECEPTOR ANTAGONISTS
    Publication number: 20130018031
    Abstract: Aminoalkylpyrimidine derivatives of formula I, wherein the meaning of the different substituents are those indicated in the description. These compounds are useful as histamine H4 receptor antagonists.
    Type: Application
    Filed: December 22, 2010
    Publication date: January 17, 2013
    Applicant: MEDICIS PHARMACEUTICAL CORPORATION
    Inventors: Elena Carceller Gonzalez, Marina Virgili Bernado, Robert Soliva Soliva, Carles Ferrer Costa
  • 4-AMINOPYRIMIDINE DERIVATIVES AS HISTAMINE H4 RECEPTOR ANTAGONISTS
    Publication number: 20110039817
    Abstract: 4-Aminopyrimidine derivatives of formula (I) that are useful as histamine H4 receptor antagonists.
    Type: Application
    Filed: December 18, 2008
    Publication date: February 17, 2011
    Inventors: Elena Carceller González, Eva María Medina Fuentes, Robert Soliva Soliva, Marina Virgili Bernadó, Josep Martí Via
  • 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
    Publication number: 20090306038
    Abstract: 2-Aminopyrimidine derivatives of formula (I) that are useful as modulators of the H4 receptor.
    Type: Application
    Filed: September 12, 2006
    Publication date: December 10, 2009
    Inventors: Elena Carceller González, Jorge Salas Solana, Robert Soliva Soliva, Eva Maria Medina Fuentes, Josep Marti Via
  • Heterocyclic amides with alpha-4 integrin antagonist activity
    Publication number: 20050143391
    Abstract: The present invention relates to new compounds of Formula (I) and the salts, solvates and prodrugs thereof, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as integrin ?4 antagonists.
    Type: Application
    Filed: April 8, 2003
    Publication date: June 30, 2005
    Applicant: J. Uriach Y Compañia S.A.
    Inventors: Elena Carceller Gonzalez, Jorge Salas Solana, Cristina Alvarez Farrerons, Juan Andreu Azanza